CDC: E-Cigarette Sales in the United States Climb As Prices Fall

Share this content:
CDC: E-Cigarette Sales in the United States Climb As Prices Fall
CDC: E-Cigarette Sales in the United States Climb As Prices Fall

FRIDAY, Aug. 3, 2018 (HealthDay News) -- There was a large increase in sales of electronic cigarettes (e-cigarettes) and related products in the United States in recent years as their prices fell, according to a study published online Aug. 2 in the U.S. Centers for Disease Control and Prevention's Preventing Chronic Disease.

Teresa W. Wang, Ph.D., from the CDC in Atlanta, and colleagues found that average monthly sales of such products rose 132 percent from 2012 to 2017.

During the same period, "average monthly prices significantly decreased in 39 states for rechargeables, in 31 states for disposables, in 20 states for pre-filled cartridges, and in eight states for e-liquids," the authors write. "Overall, U.S. e-cigarette unit sales generally increased as product prices decreased."

In related news, U.S. Food and Drug Administration officials have said that the agency is preparing a new product standard for e-cigarettes. The FDA has a number of concerns about e-cigarettes, including harmful chemicals they might contain and the risk they could get young people addicted to nicotine.

Abstract/Full Text
FDA Statement
More Information

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

CDC: U.S. Abortion Rate Declined 24 Percent From 2006 to 2015

CDC: U.S. Abortion Rate Declined 24 Percent From ...

Abortions among women ages 15-44 fell 26 percent, from 15.9 to 11.8 abortions per 1,000 women

U of Maryland Student Dies of Adenovirus-Related Illness

U of Maryland Student Dies of Adenovirus-Related Illness

CDC testing of specimen revealed adenovirus type 7, a strain that may cause more severe illness

FDA Approves Drug to Treat Rare Immune Disease

FDA Approves Drug to Treat Rare Immune Disease

Gamifant first drug to be approved specifically for primary hemophagocytic lymphohistiocytosis

is free, fast, and customized just for you!




Already a member?

Sign In Now »